利索-全球专利检索

  1. 登录
  2. 注册
发明授权
CN106674318B 一种NS5B聚合酶抑制剂 有权

一种NS5B聚合酶抑制剂
摘要：
本发明公开了一种如下式所示的化合物或其可药用盐：本发明所公开的化合物，具有优于索非布韦的治疗丙肝的效果，且毒副作用与索非布韦类似，并无明显的不良反应。
摘要（英）：

The invention discloses a compound represented by a formula shown in the description, or medicinal salts thereof. The compound has a better hepatitis C treatment effect than sofosbuvir, has similar toxic and side effects with the sofosbuvir, and does not have obvious untoward effects.

公开/授权文献
0/0